Source link : https://www.newshealth.biz/health-news/esg-more-cost-effective-long-term-than-semaglutide/
TOPLINE: Endoscopic sleeve gastroplasty (ESG) is more cost-effective, and achieves and sustains greater weight loss, than semaglutide over a 5-year period in patients with class II obesity. METHODOLOGY: Researchers used a Markov cohort model to assess the cost-effectiveness of semaglutide vs ESG over 5 years in people with class II obesity (body mass index [BMI], […]
Author : News Health
Publish date : 2024-04-12 15:00:00
Copyright for syndicated content belongs to the linked Source.